IDH1 and cancer: The results reveal that of all the 43 small molecules investigated for inhibition, only N-oxalylglycine (NOG) efficiently inhibited all three tested cancer-associated IDH1/2 variants in the presence of equimolar amounts of 2OG (Table S1).